OBJECTIVE: To measure acyl-estrone levels in the plasma of Zucker obese rats. If these are lower than expected on the basis of their body-fat content, as observed in morbidly obese humans, this might provide a possible link relating obesity and low body estrone levels. We also examined the effect of pharmacological treatment with oral oleoyl-estrone on the accumulation of estrone. DESIGN: Undisturbed Wistar, Goto-Kakizaki and Zucker (lean Fa/?and obese fa/fa) rats were used to determine the relation between circulating acyl-estrone and body lipids, as well as the total body estrone/lipid ratios. One group of Wistar rats was used to measure the effect of oral gavages of oleoyl-estrone (from 0 to 20 mmol/kg/day) for 10 days on the body content of estrone. MEASUREMENTS: Body weight change and food intake. Total estrone intake, estrone accrual and excretion (by difference) in rats receiving oleoyl-estrone. Total body lipid and estrone. Circulating acyl-estrone levels. RESULTS: In lean rats (Wistar, Zucker and Goto-Kakizaki) there was a direct relation between body lipid content and circulating acyl-estrone; this relation was not found in Zucker obese rats. The estrone/lipid mass ratio was in a similar range in lean rats, but obese animals showed much lower values. Wistar rats receiving pharmacological doses of oleoyl-estrone did not accumulate significant amounts of estrone, but excreted almost all the estrone ingested. CONCLUSIONS: The pharmacological administration of acyl-estrone to rats does not result in the accrual of estrone within a wide range of doses, which confirms the safety of this compound. In rats there is a similar relation between the percentage of body lipids and circulating acyl-estrone to that found in humans. Likewise, obese rats showed lower levels of acyl-estrone than expected. The total content of estrone in the bodies of obese rats was also lower than expected from their high lipid content, which suggests that obese rats are deficient in acyl-estrone.
Introduction
Oleoyl-estrone has been postulated as a ponderostat signal, 1 which is synthesized and stored in adipose tissue. 2 It circulates in blood mainly attached to lipoproteins. 3 Its administration to rats results in a dose-dependent loss of body fat, sparing protein. 4 The effects of oleoyl-estrone on body weight do not depend on leptin, since db/db and ob/ob mice, 5 as well as fa/fa rats, 6 lose weight when given oleoylestrone. Chronic treatment with oleoyl-estrone decreases leptin expression and circulating levels, 7 and diminishes insulin resistance and the hyperlipidaemia of Zucker obese rats. 8 Intensive oral treatment of rats with oleoyl-estrone does not produce unwanted estrogenic effects, 9 mainly because most of the estrone freed by hydrolysis in the intestine is filtered by the liver. 10 Nevertheless, most of the oleoylestrone absorbed is loaded intact into lipoproteins. 10 On the other hand, intravenous injection of oleoyl-estrone raises free estrone levels, 7 which may partly counteract the slimming action of oleoyl-estrone because of the growthpromoting effects of estrone.
11
Oleic acid is essentially the only major fatty acid esterifying estrone in plasma and fat stores of the rat, 3 but the current method of measurement, 12 (based on hydrophobic extraction, saponification and measurement of the evolved estrone through radioimmunoanalysis) can be used only for the determination of hydrophobic esters of estrone, thus the data obtained using this method should be expressed as 'acylestrone' in spite of corresponding largely to 'oleoyl-estrone'. In humans, plasma levels of acyl-estrone are directly related to their body fat mass. 13 However, this relation is not maintained in the morbidly obese, whose circulating levels of acyl-estrone are lower than expected from their body fat content. 14 Here we examined two related aspects: first whether chronic administration of pharmacological doses of oleoylestrone through daily gavage results in the accumulation of estrone in the body; and second, whether obese rats show a relative deficit in oleoyl-estrone like morbidly obese humans. These studies were performed by establishing estrone balances, in which the amount of estrone ingested (including that administered to experimental groups) and the total body content of estrone were measured.
Materials and methods

General experimental conditions
The rats were kept in standard conditions and fed a standard pellet diet (B&K, Sant Vicenç dels Horts, Spain). They were weighed daily and the food consumption was measured.
All animal handling procedures, including killing, were carried out in accordance with the authorized protocols and experimental usages authorized by the Animal Care and Ethics Committee of the University of Barcelona.
Animals were killed by decapitation with a guillotine; the blood was collected into heparinized beakers and used for the separation of plasma. The rats were then dissected and cleaned of intestinal contents. Their body remains were weighed again and sealed in polyethylene bags, which were subsequently autoclaved at 1201C for 2 h; then, the whole rat was minced to a smooth paste with a blender.
Plasma samples were used for the measurement of free and esterified estrone. 12 The proportion of lipids in the total carcass was measured following extraction with trichloromethane/methanol, 15 and total acyl-estrone from the organic phase of the lipidic extract was measured by saponification-radioimmunoanalysis. 12 Both data were referred to the body weight on the final day of the treatment; the estrone/lipid weight ratio was expressed in ppm related to the estrone nucleus. Total estrone content of the rat chow was measured in at least five samples from each pellet batch (mean value: 0.45 mmol/kg). Significant differences (Po0.05) between groups were determined using Student's t-test and standard one-way ANOVA programs.
Measurement of estrone balance in rats receiving a daily gavage of oleoyl-estrone Nine groups of six female Wistar rats weighing 190-230 g were used. A control group of intact animals was maintained with no further manipulation. All remaining groups were given, via a stomach tube, a daily gavage of 0.2 ml of sunflower oil containing oleoyl-estrone (0, 0.2, 0.5, 1.0, 2.0, 5.0, 10.0 and 20.0 mmol/kg/day). After 10 days of treatment, the rats were weighed and killed. Their body was analysed for lipid and estrone content.
Total (pellet) estrone intake E 1 for 10 days was calculated from the estrone content of food and food intake. Body estrone accrual (E A ) was calculated as the difference between the estrone content of the animals at the end of the treatment E B and that contained at the beginning of the study E 0 :
E B was determined from the final body weight W B and the estrone content in the total carcass e B :
The initial estrone content of the rat was determined from the concentration of estrone in the total carcass from intact control animals e c and the initial weights of the rats in each experimental group W 0 :
'Excreted' estrone was the difference between estrone intake and that accrued in the body. This value is in fact only an appreciation of the actual value, since it does not take into account the physiological excretion of estrone synthesized de novo.
Plasma estrone and body lipid relation's of lean and obese rats Four strains of animals were used: Wistar (from Charles River, France), Zucker lean (Fa/?) and Zucker obese (fa/fa) (from Harlan, UK) and Goto-Kakizaki (from Criffa, France).
In a group of six female rats of each strain, the food intake was recorded for 10 days in otherwise undisturbed animals maintained in metabolic cages. The animals were then weighed and killed and their plasma acyl-estrone and body lipid and estrone content were measured.
This study was complemented with other animals from these same strains, in which food intake was not measured. They were killed without additional manipulation and used only for plasma acyl-estrone and body lipid measurements, in order to establish the relations between body lipid and plasma acyl-estrone levels and the possible influence of sex in this relation. The sex and weights of the animals used in this study were: Wistar (16 males, 190-230 g; 21 females, 185-225 g), Zucker lean (eight females, 190-205 g), Zucker obese (nine males, 330-375 g; 14 females, 290-340 g) and Goto-Kakizaki (six females, 220-240 g).
The estrone balances and lipid/estrone ratios for all four strains, as well as the relations between circulating acylestrone and body lipid content, were then calculated. When establishing the total estrone balance, it was assumed that e 0 ¼ e B since the type of food ingested was the same as that in the laboratory and there were no changes in the housing conditions. Thus, all changes in estrone accrual were attributed only to variations in body weight during the period studied.
Acyl
Results
Estrone balances in rats receiving a daily gavage of oleoyl-estrone Figure 1 shows the estrone balances of Wistar rats as a function of the dose of oleoyl-estrone received during a 10-day period. There were no significant changes in body estrone within a three-order of magnitude span of daily doses. Accrual tended to increase at the lowest doses, to reach a plateau and abruptly decrease at the higher range of doses to almost undetectable values. Throughout the experiment, estrone intake (essentially the pharmacological dose of oleoyl-estrone in the gavage) was similar to the calculated excretion of the product.
Plasma estrone and body lipid relations of lean and obese rats The overall estrone balance for five female rats of four strains is presented in Table 1 . The data corresponding to accrual reflect the increases in weight observed. Although estrone intake was in the range of 6-10 nmol/day, most of this was not retained in the body. There were no significant differences between the total body estrone content in these groups in spite of differences in their body mass. However, when the total estrone content was corrected for lipid (Figure 2 ), Goto-Kakizaki rats showed a lower total estrone/ lipid ratio than Wistars, and Zucker obese rats presented much lower ratios than the other three strains of nonobese animals. The daily intake of estrone was 3-13% of body estrone. The accrual of estrone was only a small portion of either estrone intake or body estrone, since practically, all the estrone ingested was excreted.
The relation between plasma acyl-estrone and the percentage of body lipid in four strains of female rats is presented in Figure 3 . There was a high correlation between both parameters in lean rats, in spite of their considerably uniform lipid content. In contrast, obese rats showed comparable plasma estrone values, but much higher lipid content.
Discussion
The estrone intake/excretion figures described do not take into account the normal physiological synthesis of estrone in the rat tissues through aromatization of androgens, a function closely related to adipose tissue mass. 16 In all, the figures reported for daily excretion of estrone in women are again in the same range (c. 1 mmol/day) as dietary intake of estrone. 17 Since the intestinal absorption of oleoyl-estrone is high, and corresponds mainly to the ester rather than the free estrone, 10 we hypothesize both that the excretion figures reported here are much higher and that most of dietary estrone esters are absorbed. Figure 1 Log-log plot of body total estrone, estrone intake, accrual and calculated excretion vs the dose of oral oleoyl-estrone in female Wistar rats after a 10-day treatment with daily gavage of the hormone. The data are the mean values for 6 rats in each group. The data are the mean7s.e.m. of six female rats of each strain. The P-value indicates the statistical significance of the variation for each of the parameters depicted. Different superscript letters indicate statistically significant differences between groups (Po0.05, one-way ANOVA and post-hoc Duncan test).
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The data on disposal of pharmacological doses of oleoylestrone show that the body estrone pool is well maintained in spite of huge overloads of the hormone, since the accrual of estrone was unrelated to the dose, and the larger doses resulted in a loss of body estrone, substantially parallel to the disappearance of body fat. 4 These data suggest that even at pharmacological doses, the oral administration of oleoyl-estrone does not lead to the accumulation of significant amounts of estrone in the body. In addition, the results indicate a surprisingly flexible ability of the rat to dispose of large loads of dietary estrone: the rats receiving 20 mmol/kg/day of oleoyl-estrone disposed of, daily, a load in the range of 45 000 times the size of the entire circulating pool, equivalent to more than 150-fold the whole body pool of estrone. The decrease in estrone accrual at higher doses of oleoyl-estrone may be a consequence of enhanced estrone inactivation and excretion activity prompted by the presence of large amounts of the compound, probably coupled with inhibition of the production of endogenous estrone.
This outstanding estrone homeostasis suggests that these levels are very well maintained in spite of significant external chemical manipulation, which adds to their purported signaling role in the control of body weight. 1, 11 The analysis of three strains of lean rats with different mean lipid content showed that their estrone balances were fairly similar, and in line with that described for Wistar rats receiving oleoyl-estrone gavages. Dietary estrone was rapidly and effectively disposed of, and the body content of estrone was correlated with body fat in Wistar (irrespective of gender) and Zucker lean rats. Prediabetic Goto-Kakizaki animals had relatively lower estrone/lipid ratios and larger body fat masses, but Zucker obese rats had a low estrone content, both with respect to their larger size and also to their high lipid content. Estrone fatty acid esters are found mainly in adipose tissue (and, consequently, in fatty foods), 11 and thus, the total estrone body content may be related to the proportion of adipose tissue with respect to body weight; Zucker obese rats did not follow this trend. Since oleoyl-estrone induces the loss of body fat, 4, 18 increases the ability of muscle to dispose of triacylglycerols, decreases hyperlipidaemia, 8 and reduces insulin resistance, 4 the relatively low circulating levels found in obese rats (hyperlipidaemic, and insulin-resistant) are consistent with a deficit of oleoyl-estrone. All rat strains studied showed very high estrone intakes, in the range of those calculated for humans 13 in spite of lower dietary lipid levels; this is a consequence of the high estrone ester content of rat chow, and it is not surprising because a large number of human foodsFessentially those of animal originFalso contain considerable amounts of acyl-estrone. 11 This widespread distribution of estrone in dairy and other animal fatsFextensive to a number of plant derived foods 11 Fhighlights the need to monitor the possible influence of this hormonal agent on the regulation of energy and reproductive processes. The results presented here agree with both the existence of a powerful machinery favouring the excretion of very high oral overloads of estrone esters such as those found in foods, and with a direct implication of its deficit with obesity in an animal model, similar to that already observed in humans. 
Figure 3
Relation between plasma levels of acyl-estrone and percentage of body fat in four strains of male and female rats. Each symbol corresponds to the mean7s.e.m. for each group related to both axes. The number of individuals for each group is given besides the corresponding symbol. The regression line depicted was calculated using only the data corresponding to the lean rat groups: female Zucker lean (ZL F ), male (W M ) and female Wistar (W F ), and female Goto-Kakizaki (GK F ); but leaving out the male (ZO M ) and female Zucker obese (ZO F ) data.
